{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:10:21Z","timestamp":1769584221286,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.drugalcdep.2003.10.015","type":"journal-article","created":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T11:00:10Z","timestamp":1072868410000},"page":"279-287","source":"Crossref","is-referenced-by-count":53,"title":["Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans"],"prefix":"10.1016","volume":"73","author":[{"given":"Carl L","family":"Hart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie S","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Haney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W","family":"Foltin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0091-3057(00)00286-0","article-title":"Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement","volume":"66","author":"Brebner","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s002130050056","article-title":"Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules","volume":"148","author":"Brebner","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1521-0391.2003.tb00610.x","article-title":"Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients","volume":"12","author":"Campbell","year":"2003","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002130050937","article-title":"Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats","volume":"143","author":"Campbell","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<119::AID-SYN1>3.0.CO;2-F","article-title":"A novel strategy for the treatment of cocaine addiction","volume":"30","author":"Dewey","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00008877-199302000-00003","article-title":"Increased ethanol choice in social drinkers following ethanol preload","volume":"4","author":"de Wit","year":"1993","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB7","first-page":"760","article-title":"Effects of desipramine maintenance on cocaine self-administration by humans","volume":"253","author":"Fischman","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00008877-199811000-00002","article-title":"Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers","volume":"9","author":"Fischman","year":"1998","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0376-8716(90)90121-T","article-title":"Demonstration of naturalistic methods for cocaine smoking by human volunteers","volume":"26","author":"Foltin","year":"1990","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archpsyc.1984.01790200085011","article-title":"Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate","volume":"41","author":"Gawin","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB11","first-page":"636","article-title":"Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum","volume":"43","author":"Gotz","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1528-1157.1994.tb02551.x","article-title":"Efficacy and tolerance of long-term, high-dose gabapentin: additional observations","volume":"35","author":"Handforth","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s002130050418","article-title":"Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds","volume":"133","author":"Kushner","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB15","first-page":"797","article-title":"The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats","volume":"290","author":"Kushner","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jat\/16.5.311","article-title":"Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine","volume":"16","author":"Isenschmid","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB17","first-page":"403","article-title":"Baclofen as a cocaine anti-craving medication: a preliminary clinical study","volume":"18","author":"Ling","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0304-3940(91)90249-S","article-title":"Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain","volume":"128","author":"Loscher","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004714-199710000-00012","article-title":"Gabapentin abuse in a cocaine user: implications for treatment?","volume":"17","author":"Markowitz","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB20","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1111\/j.1528-1157.1999.tb00932.x","article-title":"Gabapentin in the management of convulsive disorders","volume":"40","author":"McLean","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB21","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0149-2918(03)80127-3","article-title":"Gabapentin dosing in the treatment of epilepsy","volume":"25","author":"McLean","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1528-1157.1999.tb00804.x","article-title":"Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study","volume":"40","author":"McLean","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/JCP.v62n0105","article-title":"Gabapentin in the treatment of cocaine dependence: a case series","volume":"62","author":"Myrick","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1528-1157.2000.tb00227.x","article-title":"Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients","volume":"41","author":"Petroff","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB25","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1176\/appi.ajp.157.12.2058-a","article-title":"Gabapentin therapy for cocaine cravings","volume":"157","author":"Raby","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s002130050293","article-title":"Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure","volume":"131","author":"Roberts","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0893-133X(96)00002-4","article-title":"Baclofen attenuates the reinforcing effects of cocaine in rats","volume":"15","author":"Roberts","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00213-003-1446-6","article-title":"Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine","volume":"168","author":"Schiffer","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2003.10.015_BIB29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0091-3057(00)00456-1","article-title":"The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat","volume":"68","author":"Stromberg","year":"2001","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871603003090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871603003090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T21:23:24Z","timestamp":1550265804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871603003090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0376871603003090"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2003.10.015","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}